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of people with pressure ulcers. METHODS: We combined existing 
literature and new qualitative data to develop the conceptual 
framework. The qualitative approach included semi-structured 
interviews with 32 patients with pressure ulcers. Qualitative 
interview data was analysed using framework analysis. 
RESULTS: Four HRQL domains emerged (Symptoms, Physical 
Functioning, Psychological Well-being, Social Functioning) and were 
divided into 11 sub-domains. Additional patient-reported mediating 
factors relating to experience of care (ie. satisfaction with health care, 
treatment burden) and patient factors (ie coping strategies, 
acceptance) were identified and included in the conceptual 
framework. Specific descriptive components of all conceptual 
domains will be presented. Patterns of association and interrelating 
factors in the data relating to the following subgroups were 
considered and will be discussed: age, gender, co-morbidity and PU 
severity. No gender differences emerged. CONCLUSIONS: We 
have developed a comprehensive conceptual framework of HRQL in 
pressure ulceration that incorporates existing literature and the views 
of people with pressure ulcers. This provides the basis for the 
development of a new measure of HRQL for people with pressure 
ulcers. 
1565/Predictive validity of QoL instruments in Cystic Fibrosis 
Sandra F. Scott, Margaret E. Hodson, Cystic Fibrosis, Imperial 
College, London, UK, Paul W. Jones, Respiratory Medicine, St 
George's, University of London, London, UK
AIMS: The objective of this study was to compare the ability of five 
health/symptom measures to predict an exacerbation or death in 
cystic fibrosis (CF) patients. METHODS: We used the SF-36
Physical Component Score (PCS), two validated disease-specific 
questionnaires: the CF Quality of Life Questionnaire (CFQoL) and 
Brompton CF Questionnaire (BCFQ); and 2 visual analogue scales 
(VAS) for CF: the General Chest Scale (GCS) and General QoL in 
CF (GQoL). Lung function was assessed using the FEV1. The health 
outcomes criteria were: occurrence of an exacerbation within 6 
months and survival status at 1573 days. 204 patients (mean age 29 
years, 110 females) were studied. Cox's proportional hazards models 
were used. In each model the baseline state of the patient 
(exacerbation or stable) was included as a covariate since this was 
also a predictive factor for both outcomes. RESULTS: The model r2 
values are tabulated. All are significant at 
p<0.01. CONCLUSIONS: All measures predicted both important 
future health events. Lung function appeared to be the best predictor. 
The health status questionnaires appeared to be slightly better 
predictors of outcome than the simple VAS scores of overall QoL or 
symptom level. 
Model r2 from Cox's proportional hazards model
Outcome FEV1 PCS CFQoL BCFQ GCS GQoL 
Exacerbation 0.26 0.21 0.19 0.18 0.17 0.15 
Death 0.23 0.20 0.12 0.14 0.11 0.12
1307/Development and Validation of an Adaptation Index for 
Women with Pelvic Floor Disorders (PFD) 
John T. Wei, Urology, University of Michigan, Ann Arbor, MI, 
Patricia A. Wren, School of Health Sciences, Oakland University, 
Rochester, MI, Linda Brubaker, Urology, Loyola University, 
Maywood, IL, Kathryn L. Burgio, Gerontology and Geriatric 
Medicine, University of Alabama, Birmingham, AL, Nancy K. Janz, 
Health Behavior & Health Education, University of Michigan, Ann 
Arbor, MI, Ingrid Nygaard, Obstetrics & Gynecology, University of 
Utah, Salt Lake City, UT, Rodney L. Dunn, Urology, Catherine A. 
Spino, Biostatistics, University of Michigan, Ann Arbor, MI, Susan F. 
Meikle, Obstetrics & Gynecology, NIH, Bethesda, MD, Margie A. 
Kahn, Urogynecology, Kaiser Permanenete, San Diego, CA
AIMS: Women with PFDs (i.e., pelvic organ prolapse, urinary and 
fecal incontinence) develop adaptive behaviors to deal with their 
symptoms; leading us to hypothesize that these behaviors may impact 
QOL. The purpose of this study was to develop a measure to assess 
the extent of adaptive behaviors used by women affected by 
PFDs. METHODS: Empirical studies, clinical experts, and focus 
groups of women with PFDs were used to create an initial list of 24 
items describing commonly employed adaptive behaviors. 605 
women from 4 NIH clinical trials were randomly split into 
development and validation cohorts. Scoring weights were developed 
based on the reported impact of adaptive behaviors. Convergent 
validity was assessed by correlations with validated pelvic floor 
disorder symptom distress (PFDI) and QOL 
(PFIQ). RESULTS: Confirmatory factor analysis validated 
Avoidance (11 items) and Hygiene (6 items) domains that explained 
46% of the variance with high reliability (Cronbach_s alpha 0.89 and 
0.69, respectively). Strong correlations of the Adaptation Index with 
PFDI and PFIQ (Table,*p<0.001) speaks to 
validity. CONCLUSIONS: Adaptive behaviors were found to be 
incrementally used by women with greater pelvic floor symptoms 
and greater impact on QOL. The PFDN Adaptation Index is a robust 
measure of these behaviors. 
Correlations of Adaptation Index with PFDI and PFIQ
PFDI/PFIQ subscales 
Correlation 
w/ 
Adaptation-
Hygiene 
Correlation 
w/ 
Adaptation-
Avoidance 
Urinary distress 0.40* 0.52* 
Pelvic organ prolapse distress 0.08 0.40* 
Colo-rectal-anal distress 0.38* 0.41* 
Urinary Impact 0.54* 0.74* 
Pelvic organ prolapse impact 0.25* 0.60* 
Colorectal-anal impact 0.51* 0.52* 
1398/The Effect of Health-related Quality of Life on Health 
Service Utilization and Willingness to Pay for Treatment of 
Chinese with Chronic Hepatitis B Infection 
Elegance T. Lam, Cindy L. Lam, Medicine (Family Medicine Unit), 
C.L. Lai, M.F. Yuen, Medicine, Daniel Y. Fong, Nursing Studies, 
University of Hong Kong, Hong Kong SAR, China, Thomas M. So, 
Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong 
SAR, China
AIMS: The purpose of this study was to find out whether health-
related quality of life (HRQOL) was an independent determinant of 
health service utilization and willingness to pay (WTP) for treatment 
in Chinese patients with chronic hepatitis B (CHB) 
infection. METHODS: A cross-sectional survey of 589 Chinese 
adult CHB patients (mean age of 49.7 years and 73% males) was 
carried out in Hong Kong. Health service utilization was measured by 
use of prescribed medication, consultation and hospitalization rates. 
HRQOL was measured by the SF-36 Health Survey version 2 (SF-
36v2). CHB patients were asked to state their WTP for a hypothetical 
treatment. Possion regression was used to explore the effect of 
HRQOL on consultation. Logistic regression was used to determine 
the effect of HRQOL on prescribed medication and hospitalization 
rates. Multiple linear regression analysis was performed to determine 
the effect of HRQOL on WTP. All regressions were controlled for 
socio-demographic and clinical variables. RESULTS: SF-36v2 
physical component summary (PCS) score had a significant effect on 
both doctor consultation and hospitalization rates. Lower PCS score 
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was associated with higher doctor consultation rates. Lower PCS 
score was associated with an increased likelihood of hospitalization 
in the past one year. CHB patients with higher SF-36v2 PCS score 
were more willing to pay for treatment than those with the lower PCS 
score. Conversely, patients with lower SF-36v2 mental component 
summary (MCS) score were more willing to pay for treatment than 
those with the higher MCS score. There was no statistical 
relationship between HRQOL and prescribed medication.
CONCLUSIONS: HRQOL was an important determinant of service 
utilization and WTP for treatment, implying the usefulness of 
HRQOL as an outcome measure for the prediction of service needs 
and the evaluation of treatment benefits.
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1077/A multicenter cohort study to compare quality of life in 
breast cancer patients according to sentinel lymph node biopsy or 
axillary lymph node dissection 
Tienhan S. Dabakuyo, Biostatistics and Epidemilogy, Jean FRAISSE, 
Sylvain CAUSERET, Sebastien GOUY, Marie-Martine PADEANO, 
Catherine LOUSTALOT, Jean CUISENIER, Surgery, Georges 
François Leclerc Cancer Center, DIJON, FRANCE, Jean-Marc 
SAUZEDDE, Surgery, Val de Saone general private hospital, Mâcon, 
FRANCE, Marc SMAIL, Surgery, Sainte Marie private hospital, 
Chalon sur Saône, FRANCE, Jean-Philibert COMBIER, Patrick 
CHEVILLOTE, Christian ROSBURGER, Surgery, Hotel-Dieu 
Hospital, Le CREUSOT, FRANCE, Stéphanie Boulet, Surgery, 
Patrick ARVEUX, Franck BONNETAIN, Biostatistics and 
Epidemilogy, Georges François Leclerc Cancer Center, DIJON, 
FRANCE
AIMS: This prospective multicenter study assessed and compared 
the impact of different surgical procedures on quality of life (QoL) in 
breast cancer patients. METHODS: A pragmatic prospective 
multicentric study was opened in five hospitals of the Côte d_Or and 
Saône et Loire (French provinces). All women undergoing breast 
surgery as primary treatment were eligible. The EORTC QLQ-C30 
and the EORTC QLQ-BR-23 questionnaires were used to assess the 
global health status (GHS), the arm (BRAS) and breast (BRBS) 
symptoms scales. The QoL was measured before surgery, just after 
surgery and six and twelve months later. The Kruskal-Wallis test 
with the Bonferroni correction was used to compare scores according 
to the surgical procedure. A mixed model analysis of variance for 
repeated measurements was then applied to assess the longitudinal 
effect of surgical modalities on QoL. RESULTS: Between January 
1st 2005 and January 1st 2006, 518 breast cancer patients were 
included. Two hundred thirty-five underwent axillary lymph node 
dissection (ALND), 222 patients sentinel lymph node biopsy 
(SLNB), and 61 patients had SLNB with complementary ALND. 
Before surgery, GHS (p=0.7807), BRAS (p=0.7688)QoL scores were 
similar whatever the surgical procedure: SLNB, ALND or 
SLNB+ALND. As compared with other surgical groups, GHS 
75.91(SD=17.44) and BRAS 11.39 (SD=15.36) were better in the 
SNLB group 12 months after surgery. Whatever the type of surgery, 
GHS decreased after surgery (p<0.0001), but increased 6 months 
later (p=0.0016). BRAS symptoms increased just after surgery 
(p=0.0329) and until 6 months (p<0.0001) before decreasing 
(p<0.0001). Whatever the follow up, GHS and BRAS were better in 
the SNLB group than in the SNLB+ALND. Mean differences were 
respectively 4.94 (p=0.0185) and -6.28 
(p=0.0013). CONCLUSIONS: SNLB improved QoL in breast 
cancer patients. However, surgeons must be cautious, SNLB with 
ALND results in a poorer QoL. 
1482/Quality of Care During a Six-month Chemotherapy
Treatment in Breast Cancer Patients 
Nutjaree Pratheepawanit, Faculty of Pharmaceutical Sciences, Khon 
Kaen University, Khon Kaen, Thailand, Thiti Weerapreeyakul, 
Surgery, Khon Kaen Hospital, Khon Kaen, Thailand, Areewan 
Cheawchanwattana, Faculty of Pharmaceutical Sciences, Khon Kaen 
University, Khon Kaen, Thailand
AIMS: Despite reports of chemotherapy effects on health related 
quality of life (HRQOL) of breast cancer patients, few data represent 
quality of care in routine practice and none have been conducted in a 
Thai population. This study measured the impact of chemotherapy 
treatments on HRQOL of patients with breast cancer at a 650-bed 
regional hospital in Thailand. METHODS: New breast cancer 
patients receiving chemotherapy at the study setting were recruited 
during the study period. HRQOL (FACT-B) and adverse events 
(CTCAE version3) were collected every chemotherapy cycle for six 
cycles (six months). FACT-B consists of five domains including 
Physical Well Being (PWB), Social Well Being (SWB), Emotional 
Well Being (EWB), Functional Well Being (FWB) and Breast Cancer 
Subscale (BCS). Pearson correlation was used to analyze association 
between adverse events and HRQOL. Difference of HRQOL scores, 
including TOI (PWB+FWB+BCS) reported on each cycle was tested 
using a General Linear Model. RESULTS: There were 173 patients 
recruited in this study, mean age 50 years (SD = 12), mostly married 
(73%) and having highest education of primary school (85%). 
Adverse events were reported less than 10% at baseline, except 
flushing (17%) and numbness (14%). The incidence increased from 
the 2nd cycle onward, especially weakness, flushing, anorexia, 
numbness, and vomiting with the report of around 40% at 2nd cycle 
and 50-70% during cycle 3-6. There were also significant 
associations between higher incidence of weakness, flushing and 
anorexia and lower FACT-B scores (p< 0.001). There was no 
significant difference of HRQOL during 6 months of chemotherapy 
treatment, except that BCS and TOI (p<0.005) scores were worse on 
the 2nd cycle and started to improve after the 3rd cycle. The final 
scores on the 6th cycle were also better than baseline. 
CONCLUSIONS: The findings indicate that current chemotherapy 
regimens have improved patients' HRQOL. Adverse events occurring 
during the treatment, especially weakness, flushing and anorexia can 
temporary reduce HRQOL and these should be properly treated. 
1318/Symptom and Quality of Life Assessment in Ambulatory 
Oncology: The evaluation of a clinical assessment tool. 
Susan E. Horsman, Nursing, Cross Cancer Institute, Edmonton, 
Alberta, Canada, Kärin Olson, Nursing, University of Alberta, 
Edmonton, Alberta, Canada, Heather J. Au, Oncology, Cross Cancer 
Institute, Edmonton, Alberta, Canada
AIMS: This study addresses a lack of direct HRQL information 
routinely collected as part of standard care in our outpatient oncology 
setting. The goal was to determine the relationships between 1) 
symptom scores and 2) HRQL, as measured by previously validated 
instruments, and our Ambulatory Care Flow Sheet (ACFS), a 
routinely collected patient-reported outcome (PRO) constructed by 
nursing staff. METHODS: This is a prospective, cross-sectional 
observational study of adults with colorectal cancer in an ambulatory 
care setting (n=101). Data collection was conducted at a single time 
point including: demographic information, ACFS, Rotterdam 
Symptom Checklist-Modified,(RSC-M), and EORTC QLQ 
C30. RESULTS: Results from 89 participants were evaluable. 
Correlations of symptom presence (ACFS and RSC-M) were strong 
(0.801, p<0.0001), but when including ACFS symptom severity, the 
correlation was reduced (0.183, p=0.117). The relationship between 
symptom presence and HRQL (ACFS and EORTC QLQ C30) was 
